ScholarIQanswers from OpenAlex & ORCID
Doron Lipson
ResearcherPublications, citations & collaboration network
Doron Lipson is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Doron Lipson have?
ScholarIQindexed works
Doron Lipson has 421 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Doron Lipson have?
ScholarIQcitation count
Doron Lipson has 24,295 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Doron Lipson?
ScholarIQh-index
Doron Lipson has an h-index of 67 in OpenAlex.
What is the i10-index of Doron Lipson?
ScholarIQi10-index
Doron Lipson has an i10-index of 116 in OpenAlex.
What is the ORCID of Doron Lipson?
ScholarIQorcid
The ORCID for Doron Lipson is on the source record.
What is the OpenAlex record for Doron Lipson?
ScholarIQopenalex
The OpenAlex for Doron Lipson is on the source record.
What are the most-cited papers on Doron Lipson?
ScholarIQmost cited works
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
Garrett M. Frampton, Alex Fichtenholtz, Geoff Otto, Kai Wang, Sean R. Downing, Jie He, Michael Schnall-Levin, Jared White, Eric M. Sanford, Peter An, James Sun, Frank Juhn, Kristina Brennan, Kiel Iwanik, Ashley Maillet, Jamie Buell, Emily White, Mandy Zhao, Sohail Balasubramanian, Selmira Terzic, Tina Richards, Vera Banning, Lázaro Ibrahim Romero García, Kristen Mahoney, Zac Zwirko, Amy Donahue, Himisha Beltran, Juan Miguel Mosquera, Mark A. Rubin, Snjezana Doğan, Cyrus V. Hedvat, Michael F. Berger, Lajos Pusztai, Matthias Lechner, Chris Boshoff, Mirna Jarosz, Christine Vietz, Alex Parker, Vincent A. Miller, Jeffrey S. Ross, John A. Curran, Maureen Cronin, Philip J. Stephens, Doron Lipson, Roman Yelensky
Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies
Doron Lipson, Marzia Capelletti, Roman Yelensky, Geoff Otto, Alex Parker, Mirna Jarosz, John A. Curran, Sohail Balasubramanian, Troy Bloom, Kristina Brennan, Amy Donahue, Sean R. Downing, Garrett M. Frampton, Lázaro Ibrahim Romero García, Frank Juhn, Kathy C Mitchell, Emily White, Jared White, Zac Zwirko, Tamar Peretz, Hovav Nechushtan, Lior Soussan‐Gutman, Jhingook Kim, Hidefumi Sasaki, Hyeong Ryul Kim, Seung-Il Park, Dalia Ercan, Christine E. Sheehan, Jeffrey S. Ross, Maureen Cronin, Pasi A. Jänne, Philip J. Stephens
Activation of MET via Diverse Exon 14 Splicing Alterations Occurs in Multiple Tumor Types and Confers Clinical Sensitivity to MET Inhibitors
Garrett M. Frampton, Siraj M. Ali, Mark R. Rosenzweig, Juliann Chmielecki, Xinyuan Lu, Todd M. Bauer, Mikhail Akimov, José A. Bufill, Carrie B. Lee, David Jentz, Rick Hoover, Sai‐Hong Ignatius Ou, Ravi Salgia, Timothy J. Brennan, Zachary R. Chalmers, Savina Jaeger, Alan Huang, Julia A. Elvin, Rachel Erlich, Alex Fichtenholtz, Kyle Gowen, Joel Greenbowe, Adrienne Johnson, Depinder Khaira, Caitlin McMahon, Eric M. Sanford, Steven Roels, Jared White, Joel Greshock, Robert Schlegel, Doron Lipson, Roman Yelensky, Deborah Morosini, Jeffrey S. Ross, Eric A. Collisson, Malte Peters, Philip J. Stephens, Vincent A. Miller
Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions
Christine M. Lovly, Abha A. Gupta, Doron Lipson, Geoff Otto, Tina Brennan, Catherine T. Chung, Scott C. Borinstein, Jeffrey S. Ross, Philip J. Stephens, Vincent A. Miller, Cheryl M. Coffin